Stevanato Group S.p.A. (STVN) News
Filter STVN News Items
STVN News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
STVN News Highlights
- STVN's 30 day story count now stands at 5.
- Over the past 21 days, the trend for STVN's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
- The most mentioned tickers in articles about STVN are PFS, ADD and COP.
Latest STVN News From Around the Web
Below are the latest news stories about STEVANATO GROUP SPA that investors may wish to consider to help them evaluate STVN as an investment opportunity.
Stevanato Group Collaborates with Transcoject to Provide Pre-Fillable Syringe Polymer Options for PharmaPIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, announced its latest collaboration with Transcoject GmbH, a medical device and pharma packaging solutions company. The collaboration will enable Stevanato Group to add cyclic olefin polymer (COP) and cyclic olefin copolymer (COC) PFS to its existing portfolio of solutions providing add |
Stevanato Group and Transcoject to provide pre-fillable syringe polymer options for pharmaStevanato Group (STVN) collaborates with Transcoject for adding cyclic olefin polymer ((COP)) and cyclic olefin copolymer ((COC)) PFS to its existing portfolio of solutions providing… |
Stevanato Group S.p.A.: Stevanato Group Collaborates with Transcoject to Provide Pre-Fillable Syringe Polymer Options for PharmaLeading drug containment provider to release a unique offering including both COP and COC pre-fillable syringes (PFS), adding to its existing glass PFS portfolio, providing customers with the broa… |
Stevanato Group (NYSE:STVN) investors are sitting on a loss of 12% if they invested a year agoStevanato Group S.p.A. ( NYSE:STVN ) shareholders should be happy to see the share price up 12% in the last month. In... |
Estimating The Intrinsic Value Of Stevanato Group S.p.A. (NYSE:STVN)Does the December share price for Stevanato Group S.p.A. ( NYSE:STVN ) reflect what it's really worth? Today, we will... |
Stevanato Group S.p.A. (NYSE: STVN) Shares Are Set To Rise By 2022Stevanato Group S.p.A. (NYSE:STVN) shares, rose in value on Friday, 11/18/22, with the stock price up by 2.62% to the previous day’s close as strong demand from buyers drove the stock to $14.50. Actively observing the price movement in the last trading, the stock closed the session at $14.13, falling within a range of $13.71 … Stevanato Group S.p.A. (NYSE: STVN) Shares Are Set To Rise By 2022 Read More » |
Pharmaceutical Glass Tubular Vial and Ampoule Market to Witness Huge Growth by Key Players: Schott, SGD Pharma, Gerresheimer, NIPRO, Stevanato Group, ZhengchuanThe research reports on "Pharmaceutical Glass Tubular Vial and Ampoule Market" report gives detailed overview of factors that affect global business scope. Pharmaceutical Glass Tubular Vial and Ampoule Market report shows the latest market insights with upcoming trends and breakdowns |
Stevanato Group S.p.A. (STVN) Q3 2022 Earnings Call TranscriptStevanato Group S.p.A. (NYSE:NYSE:STVN) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Lisa Miles - SVP Investor Relations Franco Stevanato - Executive… |
Stevanato Group to Present at Upcoming Investor ConferencePIOMBINO DESE, Italy, November 10, 2022--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that management will present at the Jefferies London Healthcare Conference at 12:55 p.m. (GMT) on November 17, 2022. |
Stevanato Group S.p.A.'s (NYSE:STVN) Shares May Have Run Too Fast Too SoonWith a price-to-earnings (or "P/E") ratio of 30.7x Stevanato Group S.p.A. ( NYSE:STVN ) may be sending very bearish... |